{"schema_version":1,"experiment_id":"eoa_inverse_innovation_exp06_four_proposal_generalization60_20260803","cell_id":"catalytic_pathway_enablement__chemistry_materials","arm":"COMPLETE_PROPOSAL_PORTFOLIO","candidate_id":"cpem_coatings_substitution_review_lane_v0","proposal_index":4,"version":0,"title":"Regenerative Evidence-Translation Lane for Coating-Solvent Substitution Trials","problem":"At a coatings-development facility, a formulator seeking permission for a bounded laboratory trial of a single-solvent substitution must obtain compatible interpretations from formulation chemistry, analytical testing, industrial hygiene, process engineering, waste management, and environmental health and safety. The authoritative full-review pathway can already reach a trial decision, but each otherwise prepared case repeatedly incurs evidence reformatting, terminology translation, meeting coordination, and reconstruction of unchanged requirements. The problem is whether a reusable, governed review service can lower that recurring coordination barrier without generating missing chemical evidence, weakening any acceptance criterion, or expanding trial authority.","actors":["Coatings formulators","Analytical chemists","Industrial hygienists","Process engineers","Waste-management reviewer","Environmental health and safety reviewer","Materials-governance chair","Laboratory trial-rig operator"],"observable_state":"For each proposed substitution, the facility can observe dossier completeness, eligibility result, missing or contradictory evidence, number and duration of handoffs, specialist touches, queue depth, escalation reason, conflicts of interest, decision status, imposed trial controls, downstream rig availability, post-trial deviations, template version, and steward workload and recovery state. The focal state is a technically reviewable case circulating among functions because its evidence and questions are repeatedly translated, not a case lacking required experiments or presenting an unresolved authorization conflict.","consequence":"The candidate remains untested while the currently authorized formulation remains the only permitted route, and scarce specialists repeatedly reconstruct the same review frame. If acceleration is attempted informally, requirements can be inconsistently interpreted; if every case receives unstructured full review, routine translation work can occupy capacity needed for chemically exceptional cases.","affected_objective":"Reach an accountable decision to authorize, reject, or escalate a bounded solvent-substitution laboratory trial while preserving all existing chemical compatibility, worker-protection, emissions, waste, product-performance, documentation, and downstream-capacity requirements.","intervention":"Establish a standing evidence-translation lane with a published intake contract, a versioned substitution dossier, automated completeness checks, and a rotating materials-compatibility steward. Eligibility is limited to a single declared solvent substitution within an already authorized coating platform and laboratory envelope, with verified substance identity, composition range, required hazard and compatibility evidence, analytical plan, containment plan, and waste route. The service translates an eligible dossier into the fixed questions and evidence views used by each reviewing function, convenes only the required specialists, records their determinations, and releases a bounded-trial authorization, reasoned rejection, or escalation to full review. Any novel reaction pathway, unresolved incompatibility, missing evidence, conflicting criterion, or scope change leaves the lane. After each case, the service closes access, records exceptions, refreshes dependencies, checks steward workload and conflicts, and returns the template and team to a verified ready state.","structural_mapping":[{"archetype_element":"Specified permitted transformation","domain_realization":"A complete, eligible solvent-substitution dossier becomes an accountable decision for a bounded laboratory trial, rejection, or full-review escalation under unchanged materials and safety standards."},{"archetype_element":"Recurring activation barrier","domain_realization":"Repeated evidence reformatting, terminology translation, specialist discovery, meeting coordination, and reconstruction of stable review questions delay otherwise reviewable cases."},{"archetype_element":"Reusable facilitator","domain_realization":"A standing evidence-translation service combining a versioned dossier, routing protocol, automation, and rotating compatibility steward processes successive cases and then resets for reuse."},{"archetype_element":"Facilitator–substrate interface","domain_realization":"The intake contract declares formulation scope, substance identity, concentration bounds, evidence fields, test plan, containment, waste route, requester attestations, and required metadata."},{"archetype_element":"Selectivity boundary","domain_realization":"Only objectively eligible single-solvent substitutions enter the lane; novel chemistry, incomplete evidence, unusual exposure routes, unresolved conflicts, or scope changes receive full review."},{"archetype_element":"Turnover capacity","domain_realization":"Completed decisions are counted per steward cycle together with specialist effort, returns for missing information, inappropriate admissions, escalations, post-decision deviations, and recovery time."},{"archetype_element":"Saturation and interference control","domain_realization":"Queue depth, specialist availability, trial-rig capacity, conflicted reviewers, incomplete dossiers, policy changes, and exception backlog are distinguished from facilitator degradation."},{"archetype_element":"Regeneration cycle","domain_realization":"After each case, access is closed, decisions and exceptions are logged, conflicts are cleared, current requirements are rechecked, the dossier version is validated, and steward coverage and workload are restored."},{"archetype_element":"Equilibrium neutrality","domain_realization":"The lane accelerates an already authorized decision process; it does not make an incompatible solvent compatible, supply missing evidence, redefine acceptable risk, or grant production approval."},{"archetype_element":"Accountable stewardship","domain_realization":"The materials-governance chair owns eligibility and access fairness, functional reviewers retain authority over their criteria, and rotating stewards have workload limits, refusal rights, conflict rules, and documented backup coverage."}],"mechanism_mapping":[{"mechanism_slug":"reusable_broker_or_convener_service","role":"Maintains the relationships, shared vocabulary, routing knowledge, and governed handoffs among formulation, analytical, process, hygiene, waste, and safety reviewers.","counterfactual_removal":"Each formulator would rediscover reviewers and rebuild cross-functional translation for every case, while no accountable role would own neutral access or complete handoff."},{"mechanism_slug":"embedded_specialist_review_lane","role":"Places bounded materials-compatibility judgment at the recurring point of stall, with workload caps, rotation, conflict disclosure, backup coverage, and mandatory escalation.","counterfactual_removal":"Routine interpretation would return to scattered meetings, or one informal expert could become an overloaded and unaccountable gatekeeper."},{"mechanism_slug":"interface_contract_design","role":"Declares eligible formulation scope, required evidence, metadata, reviewer guarantees, output authority, protected criteria, version, and exception conditions.","counterfactual_removal":"Ill-prepared cases would consume facilitator capacity, and scope or authority could widen through undocumented negotiation."},{"mechanism_slug":"prevalidated_transformation_template","role":"Encodes the stable sequence of completeness validation, functional review questions, constraint recording, decision assembly, and escalation without predetermining the chemical judgment.","counterfactual_removal":"Every case would reconstruct the review pathway, and omissions or inconsistent evidence views could be mistaken for reviewer discretion."},{"mechanism_slug":"fast_track_with_eligibility_rules","role":"Routes objectively bounded substitutions through the lower-friction lane while preserving every substantive criterion and returning uncertainty to full review.","counterfactual_removal":"All cases would receive the same unstructured coordination burden, or acceleration would depend on informal reviewer discretion rather than auditable eligibility."},{"mechanism_slug":"workflow_automation_or_macro","role":"Checks dossier completeness, creates reviewer-specific evidence views, tracks determinations, preserves versions, and compiles the decision record without making the approval judgment.","counterfactual_removal":"Repeated transcription and document assembly would remain, increasing handling burden and weakening auditability across turnovers."},{"mechanism_slug":"active_site_capacity_dashboard","role":"Displays steward availability, specialist queues, incomplete cases, exception backlog, review age, conflicts, trial-rig capacity, and template status.","counterfactual_removal":"Requesters could continue admitting cases when reviewer or downstream capacity is saturated, and a stale or unavailable facilitator could appear operational."},{"mechanism_slug":"catalyst_regeneration_protocol","role":"Defines post-case closure, access revocation, dependency refresh, template verification, workload recovery, conflict clearance, retraining, rotation, and retirement of stale workflow versions.","counterfactual_removal":"The service could reuse outdated requirements or exhausted human judgment while nominally remaining available."},{"mechanism_slug":"turnover_and_selectivity_assay","role":"Compares completed valid decisions, inappropriate admissions, omitted requirements, reroutes, post-decision deviations, specialist effort, and steward degradation against the existing full-review pathway.","counterfactual_removal":"Faster decisions or a high case count could conceal standard erosion, easy-case selection, unpaid specialist work, or growing exception risk."},{"mechanism_slug":"small_safe_to_fail_probe","role":"Runs the lane in nonbinding shadow mode on bounded closed dossiers before any output can authorize chemical handling or influence a live trial.","counterfactual_removal":"The facility could institutionalize the pathway without testing whether it preserves criteria, selects cases correctly, or genuinely reduces the targeted coordination barrier."}],"causal_chain":["The governance chair publishes the eligible transformation, protected criteria, intake contract, reviewer authorities, and downstream trial boundary.","A formulator submits a dossier containing the declared substance identity, formulation bounds, required evidence, analytical plan, containment conditions, and waste route.","Automated checks identify missing fields and structural inconsistencies but do not infer safety, compatibility, or approval.","The steward confirms objective eligibility and routes novel chemistry, unresolved evidence, conflicts, or scope changes to the authoritative full-review pathway.","For an eligible case, the reusable template presents each functional reviewer with the same traceable evidence in the form required for that review, avoiding repeated translation and document reconstruction.","Functional reviewers retain their substantive authority and record approval conditions, rejection reasons, evidence gaps, or escalation triggers.","The service assembles those determinations into a bounded laboratory-trial decision whose scope cannot exceed the underlying approvals or available trial-rig capacity.","The authoritative record, eligibility result, exceptions, reviewer effort, and any later trial deviation update turnover and selectivity measures.","The service closes the case, clears access and conflicts, refreshes requirements, restores steward capacity, validates the current template, and returns to a ready state for another dossier.","Missing safeguards, template drift, inappropriate admission, reviewer overload, conflict, or downstream saturation suspends new intake until the facilitator is restored or replaced."],"baseline":"Compare the lane with the facility's existing unstructured full-review pathway while holding the chemical evidence, reviewers, substantive criteria, decision authority, and trial scope constant. Measure dossier returns, handoffs, specialist touches, decision completeness, disagreement, escalation, omitted requirements, inappropriate admissions, post-decision deviations, requester effort, reviewer workload, and downstream queue. A shadow comparison must not treat agreement with a prior decision as sufficient; reviewers must also inspect whether the lane preserved the evidence, reasoning, uncertainty, and constraints supporting that decision.","nearest_rivals":["The existing ad hoc cross-functional committee, which retains full contextual judgment but reconstructs participants, evidence views, and coordination for each case.","Adding reviewers or coordinators, which increases bulk capacity without creating a selective reusable interface and regeneration cycle.","A shared document repository or chemical database, which improves access to information but does not translate a complete case through accountable review and exception routing.","A blanket approved-solvent list, which may simplify selection but cannot decide formulation-specific compatibility, exposure, processing, waste, or performance conditions.","Automatic approval based on dossier fields, which reduces handling but improperly substitutes structural completeness for substantive chemical judgment.","Delegating all decisions to one senior chemist, which may reduce coordination but concentrates authority, conflicts, workload, and succession risk."],"remaining_contrastive_claim":"The intervention qualifies as catalytic pathway enablement only if the standing service repeatedly transforms complete eligible dossiers into decisions under unchanged criteria, remains separable from each case, meters intake to real human and downstream capacity, and returns to a verified current and unconflicted state. If improvement comes from omitted reviews, relaxed evidence, added staffing, a static database, automatic approval, or one person's unchecked discretion, the proposed catalytic cycle is unsupported.","authority_safety":{"decision_authority":"The materials-governance chair may authorize only the nonbinding shadow probe after the environmental health and safety, industrial hygiene, analytical, process, waste, and data-governance owners approve the interface, protected criteria, access controls, comparison protocol, and stop rules. Existing functional authorities retain all live chemical-handling decisions.","authorized_first_step":"Freeze a shadow-mode intake contract and dossier template, appoint a primary and backup steward, select bounded already-closed internal dossiers under approved access controls, mask their final decisions, and process copies without changing any authoritative record or authorizing any laboratory work.","excluded_actions":["Authorizing chemical purchase, handling, formulation, exposure, disposal, scale-up, or production through the shadow lane","Waiving or altering any compatibility, worker-protection, emissions, waste, product-quality, analytical, or documentation requirement","Treating completeness checks or prior decisions as automatic approval","Admitting novel reaction chemistry, incomplete evidence, unresolved identity, unusual exposure routes, or out-of-scope formulations","Changing a formulation or generating missing experimental evidence on behalf of a requester","Allowing a conflicted, unavailable, or over-capacity reviewer or steward to approve a case","Expanding trial scope beyond the smallest authority granted by every required reviewer","Using confidential dossier information outside approved access and retention controls","Replacing the authoritative full-review route until a separate adoption decision is made"],"halt_rollback":"Suspend new shadow intake, preserve all dossier versions, routing records, reviewer comments, eligibility determinations, and comparison results, and mark every lane output as nonauthoritative. Return any active live matter to the existing full-review pathway. If a protected criterion was omitted or an ineligible case admitted, audit all shadow cases processed under that template version, revoke the version, correct the contract, retrain or replace the facilitator, and require renewed approval before another shadow run."},"negative_tests":{"strongest_counterevidence":"The strongest counterevidence would be that dossiers classified as routine omit chemically consequential evidence, lane reviewers identify requirements absent from the template, or the same amount of expert reconstruction remains necessary after intake. That would show either selectivity failure or that missing scientific work—not translation and coordination—is the true barrier.","problem_falsifier":"The inferred problem is falsified if case tracing shows that decision time and effort are dominated by missing experiments, laboratory or trial-rig capacity, unresolved objectives, incompatible chemistry, supplier response, or unavailable authority rather than repeated evidence translation and cross-functional handoff.","intervention_falsifier":"The intervention is falsified if shadow cases lose or weaken any existing requirement; if eligibility cannot reliably separate bounded from exceptional substitutions; if reviewer effort is merely shifted to hidden preparation or unpaid steward work; if outputs depend on one individual; if exceptions saturate the lane; or if the service cannot refresh requirements and recover human capacity between cases.","risks":["Eligibility rules may classify a chemically exceptional substitution as routine.","A structurally complete dossier may contain weak, stale, irrelevant, or misleading evidence.","Throughput pressure may turn the specialist lane into a rubber stamp.","The steward may become an unaccountable gatekeeper or favor familiar teams and chemistries.","Human workload, independence, compensation, refusal rights, and recovery may be treated as inexhaustible capacity.","A template may lag changes in formulation, equipment, analytical methods, exposure assumptions, waste routes, or governing requirements.","Automation may copy an error consistently across reviewer views and decision records.","Confidential formulation, supplier, hazard, or exposure information may be disclosed beyond authorized reviewers.","Fast-lane access may advantage teams with more dossier-preparation support.","Reviewer conflicts or organizational incentives may distort ostensibly neutral translation.","The lane may accelerate authorizations beyond the available analytical, containment, waste, or trial-rig capacity.","A favorable shadow result on routine closed cases may not represent live ambiguity or changed requirements."]},"next_evidence_step":"Run a nonbinding shadow probe on no more than eight already-closed internal solvent-substitution dossiers selected before outcome unmasking under approved information controls. Include dossiers expected by the predeclared eligibility signals to span complete routine cases, incomplete cases, and cases containing escalation triggers. Two rotating stewards independently apply the frozen intake and routing rules; required functional reviewers assess the lane-generated evidence views without seeing the original final decision. Record eligibility agreement, missing or distorted evidence, inappropriate admissions, escalations, handoffs, specialist touches, reviewer and requester effort, protected criteria preserved, decision constraints, conflicts, exception backlog, steward workload, and template-reset work. Then unmask the authoritative record and conduct criterion-by-criterion comparison, including whether prior reasoning itself contained uncertainty or omissions. Predeclare stop rules before selection. End the probe if any protected requirement is weakened, an ineligible case is fast-tracked, confidential access fails, hidden work accounts for the apparent acceleration, or the facilitator cannot return to a current and adequately staffed ready state.","prior_art_status":"UNSEARCHED","diversity_from_prior_proposals":"This proposal is independent of proposals 1, 2, and 3. Proposal 1 performs enzymatic bond cleavage on PET-rich textile fines using an immobilized biocatalyst basket; proposal 4 neither processes polymers nor produces chemical depolymerization products, and its facilitator is a governed review service rather than a reactor artifact. Proposal 2 converts raw diffraction scans into cross-instrument-comparable records through reference coupons and a deterministic calibration transform; proposal 4 does not calibrate instruments or alter measurement coordinates, and instead coordinates distinct expert judgments to produce a bounded trial decision from a complete evidence dossier. Proposal 3 initiates crystallization and heat release in salt-hydrate material through a microtextured nucleation insert; proposal 4 causes no physical phase transition and uses no nucleating surface or thermal cycle. Its barrier is repeated cross-functional translation and coordination in coatings governance, its substrate is a prepared substitution dossier, its facilitator is an accountable human-and-informational service, and its output is a constrained authorization, rejection, or escalation. It can be adopted without the PET reactor, diffraction gateway, or thermal-storage module and is not a monitoring or approval feature of any of them.","revision_record":{"parent_version":null,"progress_targets_addressed":[],"conceptual_changes":[],"operational_changes":[],"evidence_changes":[],"claim_changes":[]}}